Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan.
Toshinari AsakuraShuichi SuzukiToshihiko AranishiZhihong CaiPublished in: Current medical research and opinion (2018)
In this study, participants required a shorter training time to achieve correct administration with the dulaglutide SUP, and had a higher preference for the dulaglutide SUP, when compared to FlexTouch®. These data suggest that the dulaglutide SUP is easy-to-use, which may decrease the burden on HCPs to train diabetic patients how to administer injection therapy and reduce patient injection hurdles, such as needle fear.
Keyphrases
- ultrasound guided
- end stage renal disease
- type diabetes
- ejection fraction
- electronic health record
- newly diagnosed
- chronic kidney disease
- stem cells
- healthcare
- prognostic factors
- risk factors
- metabolic syndrome
- adipose tissue
- insulin resistance
- bone marrow
- high resolution
- peritoneal dialysis
- skeletal muscle
- health information
- artificial intelligence
- glycemic control